[1]
2024. Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s497. DOI:https://doi.org/10.25251/skin.8.supp.497.